These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

660 related items for PubMed ID: 17981914

  • 61. [Seroconversion after vaccine with trivalent influenza vaccine during the epidemic season 1990/1 in Poland].
    Brydak L, Rudnicka H, Gut W, Magdzik W, Kańtoch M.
    Przegl Epidemiol; 1992; 46(3):221-9. PubMed ID: 1296247
    [Abstract] [Full Text] [Related]

  • 62. The humoral immune response of hematopoietic stem cell transplantation recipients to AS03-adjuvanted A/California/7/2009 (H1N1)v-like virus vaccine during the 2009 pandemic.
    Engelhard D, Zakay-Rones Z, Shapira MY, Resnick I, Averbuch D, Grisariu S, Dray L, Djian E, Strauss-Liviatan N, Grotto I, Wolf DG, Or R.
    Vaccine; 2011 Feb 17; 29(9):1777-82. PubMed ID: 21216315
    [Abstract] [Full Text] [Related]

  • 63. Dose sparing strategy with intradermal influenza vaccination in patients with solid cancer.
    Jo YM, Song JY, Hwang IS, Lee J, Oh SC, Kim JS, Kim SR, Kim WJ, Cheong HJ.
    J Med Virol; 2009 Apr 17; 81(4):722-7. PubMed ID: 19235853
    [Abstract] [Full Text] [Related]

  • 64. Long-lasting immunogenicity of a virosomal vaccine in older children and young adults with type I diabetes mellitus.
    Zuccotti GV, Scaramuzza A, Riboni S, Mameli C, Pariani E, Tanzi E, Zanetti A, Radaelli G.
    Vaccine; 2009 Aug 27; 27(39):5357-62. PubMed ID: 19607951
    [Abstract] [Full Text] [Related]

  • 65. The response to vaccination against influenza A(H1N1) 2009, seasonal influenza and Streptococcus pneumoniae in adult outpatients with ongoing treatment for cancer with and without rituximab.
    Berglund A, Willén L, Grödeberg L, Skattum L, Hagberg H, Pauksens K.
    Acta Oncol; 2014 Sep 27; 53(9):1212-20. PubMed ID: 24865118
    [Abstract] [Full Text] [Related]

  • 66. Shedding and immunogenicity of live attenuated influenza vaccine virus in subjects 5-49 years of age.
    Block SL, Yogev R, Hayden FG, Ambrose CS, Zeng W, Walker RE.
    Vaccine; 2008 Sep 08; 26(38):4940-6. PubMed ID: 18662737
    [Abstract] [Full Text] [Related]

  • 67. Residual inflammation after rituximab treatment is associated with sustained synovial plasma cell infiltration and enhanced B cell repopulation.
    Teng YK, Levarht EW, Toes RE, Huizinga TW, van Laar JM.
    Ann Rheum Dis; 2009 Jun 08; 68(6):1011-6. PubMed ID: 18647852
    [Abstract] [Full Text] [Related]

  • 68. A TritonX-100-split virion influenza vaccine is safe and fulfills the committee for proprietary medicinal products (CPMP) recommendations for the European Community for Immunogenicity, in Children, Adults and the Elderly.
    Lina B, Fletcher MA, Valette M, Saliou P, Aymard M.
    Biologicals; 2000 Jun 08; 28(2):95-103. PubMed ID: 10885616
    [Abstract] [Full Text] [Related]

  • 69. Disease activity-guided rituximab therapy in rheumatoid arthritis: the effects of re-treatment in initial nonresponders versus initial responders.
    Thurlings RM, Vos K, Gerlag DM, Tak PP.
    Arthritis Rheum; 2008 Dec 08; 58(12):3657-64. PubMed ID: 19035505
    [Abstract] [Full Text] [Related]

  • 70. Influenza vaccination in patients with breast cancer: a case-series analysis.
    Vilar-Compte D, Cornejo P, Valle-Salinas A, Roldán-Marin R, Iguala M, Cervantes Y, López I.
    Med Sci Monit; 2006 Aug 08; 12(8):CR332-6. PubMed ID: 16865064
    [Abstract] [Full Text] [Related]

  • 71. Influenza immunisation in children with solid tumours.
    Chisholm J, Howe K, Taj M, Zambon M.
    Eur J Cancer; 2005 Oct 08; 41(15):2280-7. PubMed ID: 16143516
    [Abstract] [Full Text] [Related]

  • 72. Half- vs full-dose trivalent inactivated influenza vaccine (2004-2005): age, dose, and sex effects on immune responses.
    Engler RJ, Nelson MR, Klote MM, VanRaden MJ, Huang CY, Cox NJ, Klimov A, Keitel WA, Nichol KL, Carr WW, Treanor JJ, Walter Reed Health Care System Influenza Vaccine Consortium.
    Arch Intern Med; 2008 Dec 08; 168(22):2405-14. PubMed ID: 19064822
    [Abstract] [Full Text] [Related]

  • 73. Rituximab impairs immunoglobulin (Ig)M and IgG (subclass) responses after influenza vaccination in rheumatoid arthritis patients.
    Westra J, van Assen S, Wilting KR, Land J, Horst G, de Haan A, Bijl M.
    Clin Exp Immunol; 2014 Oct 08; 178(1):40-7. PubMed ID: 24889761
    [Abstract] [Full Text] [Related]

  • 74. [Influenza vaccination of children with hemophilia].
    Klukowska A, Brydak L, Rokicka-Milewska R, Gosk B, Wielopolska M, Adamowicz-Salach A, Rudnicka H, Regnery H, Cox N.
    Acta Haematol Pol; 1995 Oct 08; 26(3):305-10. PubMed ID: 8525777
    [Abstract] [Full Text] [Related]

  • 75. An influenza A/H3 outbreak during the 2004/2005 winter in elderly vaccinated people living in a nursing home.
    Iorio AM, Neri M, Lepri E, Camilloni B, Basileo M, Sigismondi N, Fabiani C, Calzoletti L, Puzelli S, Donatelli I.
    Vaccine; 2006 Nov 10; 24(44-46):6615-9. PubMed ID: 16828941
    [Abstract] [Full Text] [Related]

  • 76. Early effects of rituximab on the synovial cell infiltrate in patients with rheumatoid arthritis.
    Vos K, Thurlings RM, Wijbrandts CA, van Schaardenburg D, Gerlag DM, Tak PP.
    Arthritis Rheum; 2007 Mar 10; 56(3):772-8. PubMed ID: 17328049
    [Abstract] [Full Text] [Related]

  • 77. The immunogenicity of intradermal influenza vaccination in COPD patients.
    Chuaychoo B, Wongsurakiat P, Nana A, Kositanont U, Maranetra KN.
    Vaccine; 2010 May 28; 28(24):4045-51. PubMed ID: 20412877
    [Abstract] [Full Text] [Related]

  • 78. Immunization responses in rheumatoid arthritis patients treated with rituximab: results from a controlled clinical trial.
    Bingham CO, Looney RJ, Deodhar A, Halsey N, Greenwald M, Codding C, Trzaskoma B, Martin F, Agarwal S, Kelman A.
    Arthritis Rheum; 2010 Jan 28; 62(1):64-74. PubMed ID: 20039397
    [Abstract] [Full Text] [Related]

  • 79. Antibody response to a two-dose regimen of influenza vaccine in allogeneic T cell-depleted and autologous BMT recipients.
    Engelhard D, Nagler A, Hardan I, Morag A, Aker M, Baciu H, Strauss N, Parag G, Naparstek E, Ravid Z.
    Bone Marrow Transplant; 1993 Jan 28; 11(1):1-5. PubMed ID: 8431706
    [Abstract] [Full Text] [Related]

  • 80. Studies of cell-mediated immune responses to influenza vaccination in systemic lupus erythematosus.
    Holvast A, van Assen S, de Haan A, Huckriede A, Benne CA, Westra J, Palache A, Wilschut J, Kallenberg CG, Bijl M.
    Arthritis Rheum; 2009 Aug 28; 60(8):2438-47. PubMed ID: 19644961
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 33.